Impact of serum tumor marker determination on the management of women with borderline ovarian tumors: multivariate analysis of a French multicentre study.

Date publication

novembre 2010

Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr COUTANT Charles

Tous les auteurs :
Poncelet C, Fauvet R, Yazbeck C, Coutant C, Darai E

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/20817462

Résumé

To evaluate the contribution of preoperative serum tumor markers to manage borderline ovarian tumors (BOT).

Mots clés

Adult, Aged, Analysis of Variance, Ascites, etiology, Biomarkers, Tumor, blood, CA-125 Antigen, blood, CA-19-9 Antigen, blood, Carcinoembryonic Antigen, blood, Female, Follow-Up Studies, France, Frozen Sections, Humans, Laparoscopy, Laparotomy, Logistic Models, Middle Aged, Mucin-1, blood, Neoplasm Staging, Ovarian Neoplasms, blood, Radioimmunoassay, Retrospective Studies, Severity of Illness Index

Référence

Eur J Surg Oncol. 2010 Nov;36(11):1066-72